Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

23-05-2020 | Original Paper

Dysbiosis of Gut Fungal Microbiota in Children with Autism Spectrum Disorders

Auteurs: Rong Zou, Yuezhu Wang, Mengmeng Duan, Min Guo, Qiang Zhang, Huajun Zheng

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 1/2021

Abstract

In this study, we tested the feces of children with ASD and those of healthy children, and the overall changing of the gut fungal community was observed in ASD children compared with controls. However, there were no abundant fungi populations showed significant variations between the ASD and Control group both at phylum and class level. Among the 507 genera identified, Saccharomyces and Aspergillus showed significant differences between ASD (59.07%) and Control (40.36%), indicating that they may be involved in the abnormal gut fungal community structure of ASD. When analyzed at the species level, a decreased abundance in Aspergillus versicolor was observed while Saccharomyces cerevisiae was increased in children with ASD relative to controls. Overall, this study characterized the fungal microbiota profile of children with ASD and identified potential diagnostic species closely related to the immune response in ASD.

vorige artikel Strategic Deception in Adults with Autism Spectrum Disorder

volgende artikel Copy Number Variants and Polygenic Risk Scores Predict Need of Care in Autism and/or ADHD Families

Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011). Gastrointestinal flora and gastrointestinal status in children with autism - comparisons to typical children and correlation with autism severity. BMC Gastroenterology, 11, 22. https://doi.org/10.1186/1471-230x-11-22.CrossRefPubMedPubMedCentral

Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Al-Ayadhi, L. Y., Alotaibi, M. R., et al. (2019). Dysregulation of T cell immunoglobulin and mucin domain 3 (TIM-3) signaling in peripheral immune cells is associated with immune dysfunction in autistic children. Molecular Immunology, 106, 77–86. https://doi.org/10.1016/j.molimm.2018.12.020.CrossRefPubMed

Andersen, L. O., Vedel Nielsen, H., & Stensvold, C. R. (2013). Waiting for the human intestinal Eukaryotome. ISME Journal, 7(7), 1253–1255. https://doi.org/10.1038/ismej.2013.21.CrossRefPubMedPubMedCentral

Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., et al. (2018). Prevalence of autism spectrum disorder among children aged 8 years - Autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveillance Summary, 67(6), 1–23. https://doi.org/10.15585/mmwr.ss6706a1.CrossRef

Bell, C. C. (1994). DSM-IV: Diagnostic and statistical manual of mental disorders. Essentials of Pain Medicine, 272(10), 828–829.

Berding, K., & Donovan, S. M. (2018). Diet can impact microbiota composition in children with autism spectrum disorder. Frontiers in Neuroscience, 12, 515. https://doi.org/10.3389/fnins.2018.00515.CrossRefPubMedPubMedCentral

Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A., et al. (2019). Author correction: Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nature Biotechnology, 37(9), 1091. https://doi.org/10.1038/s41587-019-0252-6.CrossRefPubMed

Borre, Y. E., Moloney, R. D., Clarke, G., Dinan, T. G., & Cryan, J. F. (2014). The impact of microbiota on brain and behavior: Mechanisms & therapeutic potential. Advances in Experimental Medicine and Biology, 817, 373–403. https://doi.org/10.1007/978-1-4939-0897-4_17.CrossRefPubMed

Burrus, C. J. (2012). A biochemical rationale for the interaction between gastrointestinal yeast and autism. Medical Hypotheses, 79(6), 784–785. https://doi.org/10.1016/j.mehy.2012.08.029.CrossRefPubMed

Chen, R., Liu, D., Guo, P., & Lin, W. (2018). Varicuothiols A and B, new fungal metabolites from Aspergillus versicolor with anti-inflammatory activities. Chemistry & Biodiversity, 15(1), e1700445. https://doi.org/10.1002/cbdv.201700445.CrossRef

Cheng, S. C., van de Veerdonk, F., Smeekens, S., Joosten, L. A., van der Meer, J. W., Kullberg, B. J., et al. (2010). Candida albicans dampens host defense by downregulating IL-17 production. The Journal of Immunology, 185(4), 2450–2457. https://doi.org/10.4049/jimmunol.1000756.CrossRefPubMed

Collins, S. M., & Bercik, P. (2009). The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology, 136(6), 2003–2014. https://doi.org/10.1053/j.gastro.2009.01.075.CrossRefPubMed

David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505(7484), 559–563. https://doi.org/10.1038/nature12820.CrossRefPubMed

Finegold, S. M. (2011). Desulfovibrio species are potentially important in regressive autism. Medical Hypotheses, 77(2), 270–274. https://doi.org/10.1016/j.mehy.2011.04.032.CrossRefPubMed

Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., et al. (2010). Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe, 16(4), 444–453. https://doi.org/10.1016/j.anaerobe.2010.06.008.CrossRefPubMed

Gabriele, S., Sacco, R., & Persico, A. M. (2014). Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis. European Neuropsychopharmacology, 24(6), 919–929. https://doi.org/10.1016/j.euroneuro.2014.02.004.CrossRefPubMed

Hittinger, C. T. (2013). Saccharomyces diversity and evolution: A budding model genus. Trends in Genetics, 29(5), 309–317. https://doi.org/10.1016/j.tig.2013.01.002.CrossRefPubMed

Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H., Wu, G. D., et al. (2013). Archaea and fungi of the human gut microbiome: Correlations with diet and bacterial residents. PLoS ONE, 8(6), e66019. https://doi.org/10.1371/journal.pone.0066019.CrossRefPubMedPubMedCentral

Iovene, M. R., Bombace, F., Maresca, R., Sapone, A., Iardino, P., Picardi, A., et al. (2017). Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders. Mycopathologia, 182(3–4), 349–363. https://doi.org/10.1007/s11046-016-0068-6.CrossRefPubMed

Kaluzna-Czaplinska, J., & Blaszczyk, S. (2012). The level of arabinitol in autistic children after probiotic therapy. Nutrition, 28(2), 124–126. https://doi.org/10.1016/j.nut.2011.08.002.CrossRefPubMed

Kantarcioglu, A. S., Kiraz, N., & Aydin, A. (2016). Microbiota-gut-brain axis: Yeast species isolated from stool samples of children with suspected or diagnosed autism spectrum disorders and in vitro susceptibility against nystatin and fluconazole. Mycopathologia, 181(1–2), 1–7. https://doi.org/10.1007/s11046-015-9949-3.CrossRefPubMed

Kidd, P. M. (2002). Autism, an extreme challenge to integrative medicine. Part 2: Medical management. Alternative Medicine Review, 7(6), 472–499.PubMed

Kim, Y. S., & Leventhal, B. L. (2015). Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders. Biological Psychiatry, 77(1), 66–74. https://doi.org/10.1016/j.biopsych.2014.11.001.CrossRefPubMed

Kobliner, V., Mumper, E., & Baker, S. M. (2018). Reduction in obsessive compulsive disorder and self-injurious behavior with Saccharomyces boulardii in a child with autism: A case report. Integrative Medicine (Encinitas), 17(6), 38–41.

Kohler, J. R., Hube, B., Puccia, R., Casadevall, A., & Perfect, J. R. (2017). Fungi that infect humans. Microbiol Spectrum, 5(3), a019273. https://doi.org/10.1128/microbiolspec.FUNK-0014-2016.CrossRef

Kuhbacher, T., Ott, S. J., Helwig, U., Mimura, T., Rizzello, F., Kleessen, B., et al. (2006). Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut, 55(6), 833–841. https://doi.org/10.1136/gut.2005.078303.CrossRefPubMedPubMedCentral

Liu, F., Li, J., Wu, F., Zheng, H., Peng, Q., & Zhou, H. (2019). Altered composition and function of intestinal microbiota in autism spectrum disorders: A systematic review. Translational psychiatry, 9(1), 43. https://doi.org/10.1038/s41398-019-0389-6.CrossRefPubMedPubMedCentral

Lord, C., & Bishop, S. L. (2015). Recent advances in autism research as reflected in DSM-5 criteria for autism spectrum disorder. Annual Review of Clinical Psychology, 11, 53–70. https://doi.org/10.1146/annurev-clinpsy-032814-112745.CrossRefPubMed

Macfarlane, S., & Dillon, J. F. (2007). Microbial biofilms in the human gastrointestinal tract. Journal of Applied Microbiology, 102(5), 1187–1196. https://doi.org/10.1111/j.1365-2672.2007.03287.x.CrossRefPubMed

Marra, A. R., Opilla, M., Edmond, M. B., & Kirby, D. F. (2007). Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. Journal of Clinical Gastroenterology, 41(1), 19–28. https://doi.org/10.1097/01.mcg.0000212606.13348.f7.CrossRefPubMed

Meltzer, A., & Van de Water, J. (2017). The role of the immune system in autism spectrum disorder. Neuropsychopharmacology, 42(1), 284–298. https://doi.org/10.1038/npp.2016.158.CrossRefPubMed

Noto, A., Fanos, V., Barberini, L., Grapov, D., Fattuoni, C., Zaffanello, M., et al. (2014). The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings. The Journal of Maternal-Fetal & Neonatal Medicine, 27(Suppl 2), 46–52. https://doi.org/10.3109/14767058.2014.954784.CrossRef

Ormstad, H., Bryn, V., Verkerk, R., Skjeldal, O. H., Halvorsen, B., Saugstad, O. D., et al. (2018). Serum tryptophan, tryptophan catabolites and brain-derived neurotrophic factor in subgroups of youngsters with autism spectrum disorders. CNS & Neurological Disorders: Drug Targets, 17(8), 626–639. https://doi.org/10.2174/1871527317666180720163221.CrossRef

Pais, P., Costa, C., Cavalheiro, M., Romao, D., & Teixeira, M. C. (2016). Transcriptional control of drug resistance, virulence and immune system evasion in pathogenic fungi: A cross-species comparison. Frontiers in Cellular and Infection Microbiology, 6, 131. https://doi.org/10.3389/fcimb.2016.00131.CrossRefPubMedPubMedCentral

Parks, D. H., Tyson, G. W., Hugenholtz, P., & Beiko, R. G. (2014). STAMP: Statistical analysis of taxonomic and functional profiles. Bioinformatics, 30(21), 3123–3124. https://doi.org/10.1093/bioinformatics/btu494.CrossRefPubMedPubMedCentral

Reichelt, K. L., & Knivsberg, A. M. (2009). The possibility and probability of a gut-to-brain connection in autism. Annals of Clinical Psychiatry, 21(4), 205–211.PubMed

Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009). Principles and clinical implications of the brain-gut-enteric microbiota axis. Nature Reviews Gastroenterology & Hepatology, 6(5), 306–314. https://doi.org/10.1038/nrgastro.2009.35.CrossRef

Rizzetto, L., Ifrim, D. C., Moretti, S., Tocci, N., Cheng, S. C., Quintin, J., et al. (2016). Fungal chitin induces trained immunity in human monocytes during cross-talk of the host with Saccharomyces cerevisiae. Journal of Biological Chemistry, 291(15), 7961–7972. https://doi.org/10.1074/jbc.M115.699645.CrossRefPubMedPubMedCentral

Rosenfeld, C. S. (2015). Microbiome disturbances and autism spectrum disorders. Drug Metabolism and Disposition, 43(10), 1557–1571. https://doi.org/10.1124/dmd.115.063826.CrossRefPubMed

Sanata, B., Salam, O. A., Ibrahim, S., Adama, Z., Mamoudou, C., Simplice, K. D., et al. (2014). Digestive fungal flora in asymptomatic subjects in Bobo-Dioulasso, Burkina Faso. Asian Pacific Journal of Tropical Biomedicine, 4(8), 659–662. https://doi.org/10.12980/apjtb.4.201414b27.CrossRefPubMedPubMedCentral

Sauer, A. K., Bockmann, J., Steinestel, K., Boeckers, T. M., & Grabrucker, A. M. (2019). Altered intestinal morphology and microbiota composition in the autism spectrum disorders associated SHANK3 mouse model. International Journal of Molecular Sciences, 20(9), 2134. https://doi.org/10.3390/ijms20092134.CrossRefPubMedCentral

Severance, E. G., Alaedini, A., Yang, S., Halling, M., Gressitt, K. L., Stallings, C. R., et al. (2012). Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophrenia Research, 138(1), 48–53. https://doi.org/10.1016/j.schres.2012.02.025.CrossRefPubMed

Severance, E. G., Gressitt, K. L., Stallings, C. R., Katsafanas, E., Schweinfurth, L. A., Savage, C. L. G., et al. (2017). Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study. Brain, Behavior, and Immunity, 62, 41–45. https://doi.org/10.1016/j.bbi.2016.11.019.CrossRefPubMed

Smith-Brown, P., Morrison, M., Krause, L., & Davies, P. S. (2016). Dairy and plant based food intakes are associated with altered faecal microbiota in 2 to 3 year old Australian children. Scientific Reports, 6, 32385. https://doi.org/10.1038/srep32385.CrossRefPubMedPubMedCentral

Stanzani, M., Orciuolo, E., Lewis, R., Kontoyiannis, D. P., Martins, S. L., St John, L. S., et al. (2005). Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood, 105(6), 2258–2265. https://doi.org/10.1182/blood-2004-09-3421.CrossRefPubMed

Strati, F., Cavalieri, D., Albanese, D., De Felice, C., Donati, C., Hayek, J., et al. (2017). New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome, 5(1), 24. https://doi.org/10.1186/s40168-017-0242-1.CrossRefPubMedPubMedCentral

Suhr, M. J., Banjara, N., & Hallen-Adams, H. E. (2016). Sequence-based methods for detecting and evaluating the human gut mycobiome. Letters in Applied Microbiology, 62(3), 209–215. https://doi.org/10.1111/lam.12539.CrossRefPubMed

Sun, X., Allison, C., Wei, L., Matthews, F. E., Auyeung, B., Wu, Y. Y., et al. (2019). Autism prevalence in China is comparable to Western prevalence. Molecular Autism, 10, 7. https://doi.org/10.1186/s13229-018-0246-0.CrossRefPubMedPubMedCentral

Ukhanova, M., Wang, X., Baer, D. J., Novotny, J. A., Fredborg, M., & Mai, V. (2014). Effects of almond and pistachio consumption on gut microbiota composition in a randomised cross-over human feeding study. British Journal of Nutrition, 111(12), 2146–2152. https://doi.org/10.1017/s0007114514000385.CrossRefPubMed

Wang, L., Christophersen, C. T., Sorich, M. J., Gerber, J. P., Angley, M. T., & Conlon, M. A. (2011). Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Applied and Environmental Microbiology, 77(18), 6718–6721. https://doi.org/10.1128/aem.05212-11.CrossRefPubMedPubMedCentral

Williams, B. L., Hornig, M., Parekh, T., & Lipkin, W. I. (2012). Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio, 3(1), 1–11. https://doi.org/10.1128/mBio.00261-11.CrossRef

Wilson, D. (2017). A tale of two yeasts: Saccharomyces cerevisiae as a therapeutic against candidiasis. Virulence, 8(1), 15–17. https://doi.org/10.1080/21505594.2016.1230580.CrossRefPubMed

Zheng, Z., Zhu, T., Qu, Y., & Mu, D. (2016). Blood glutamate levels in autism spectrum disorder: A systematic review and meta-analysis. PLoS ONE, 11(7), e0158688. https://doi.org/10.1371/journal.pone.0158688.CrossRefPubMedPubMedCentral

Zimmermann, K., Haas, A., & Oxenius, A. (2012). Systemic antibody responses to gut microbes in health and disease. Gut Microbes, 3(1), 42–47. https://doi.org/10.4161/gmic.19344.CrossRefPubMed

Titel: Dysbiosis of Gut Fungal Microbiota in Children with Autism Spectrum Disorders
Auteurs: Rong Zou
Yuezhu Wang
Mengmeng Duan
Min Guo
Qiang Zhang
Huajun Zheng
Publicatiedatum: 23-05-2020
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 1/2021
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-020-04543-y

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2021

Generalized Effects of Naturalistic Social Communication Intervention for Minimally Verbal Children with Autism

Vocational Rehabilitation Service Utilization and Employment Outcomes Among Secondary Students on the Autism Spectrum

Meeting the Mental Health Needs of College Students with ASD: A Survey of University and College Counseling Center Directors

Strategies for Research, Practice, and Policy for Autism in Later Life: A Report from a Think Tank on Aging and Autism

Atypical Topographical Organization of Global Form and Motion Processing in 5-Month-Old Infants at Risk for Autism

IQ and Sensory Symptom Severity Best Predict Motor Ability in Children With and Without Autism Spectrum Disorder